Carter Jennifer L. 4
4 · Oncocyte Corp · Filed Aug 17, 2022
Insider Transaction Report
Form 4
Carter Jennifer L.
Director
Transactions
- Award
Option to Purchase Common Stock
2022-08-15+45,000→ 45,000 totalExercise: $0.97Exp: 2032-08-15→ Common Stock (45,000 underlying) - Award
Common Stock, no par value
2022-08-15+10,000→ 20,000 total - Purchase
Common Stock, no par value
2022-08-16$0.95/sh+10,500$9,975→ 30,500 total
Footnotes (2)
- [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
- [F2]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.